A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223

被引:795
作者
Wang, Kun [1 ]
Long, Bo [2 ,3 ]
Liu, Fang [4 ]
Wang, Jian-Xun [1 ]
Liu, Cui-Yun [1 ]
Zhao, Bing [1 ]
Zhou, Lu-Yu [1 ]
Sun, Teng [1 ]
Wang, Man [1 ]
Yu, Tao [1 ]
Gong, Ying [1 ]
Liu, Jia [1 ]
Dong, Yan-Han [1 ]
Li, Na [1 ]
Li, Pei-Feng [1 ]
机构
[1] Qingdao Univ, Inst Translat Med, Coll Med, Ctr Dev Cardiol, Qingdao 266021, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Cent Res Lab, Lab Mol Med, Beijing 100730, Peoples R China
[3] Peking Union Med Coll, Beijing 100730, Peoples R China
[4] Guilin Med Univ, Dept Anat, Coll Basic Med, Guilin 541004, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
Circular RNA; HRCR; Cardiac hypertrophy; Heart failure; CASPASE RECRUITMENT DOMAIN; MUSCLE-SPECIFIC MICRORNA; CARDIAC-HYPERTROPHY; APOPTOSIS REPRESSOR; CARDIOMYOCYTE HYPERTROPHY; CELL PROLIFERATION; SKELETAL-MUSCLE; DIFFERENTIATION; OVEREXPRESSION; TRANSCRIPTS;
D O I
10.1093/eurheartj/ehv713
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Our present study reveals a novel cardiac hypertrophic regulating model that is composed of circRNA, miR-223, and ARC. Modulation of their levels may provide a new approach for tackling cardiac hypertrophy and heart failure. Our present work advances our understanding about the role of circRNAs and miRNAs in cardiac hypertrophy and heart failure. Circular RNA may represent a potential new therapeutic strategy to attenuate the pathogenesis of cardiac diseases.Sustained cardiac hypertrophy accompanied by maladaptive cardiac remodelling represents an early event in the clinical course leading to heart failure. Maladaptive hypertrophy is considered to be a therapeutic target for heart failure. However, the molecular mechanisms that regulate cardiac hypertrophy are largely unknown. Here we show that a circular RNA (circRNA), which we term heart-related circRNA (HRCR), acts as an endogenous miR-223 sponge to inhibit cardiac hypertrophy and heart failure. miR-223 transgenic mice developed cardiac hypertrophy and heart failure, whereas miR-223-deficient mice were protected from hypertrophic stimuli, indicating that miR-223 acts as a positive regulator of cardiac hypertrophy. We identified ARC as a miR-223 downstream target to mediate the function of miR-223 in cardiac hypertrophy. Apoptosis repressor with CARD domain transgenic mice showed reduced hypertrophic responses. Further, we found that a circRNA HRCR functions as an endogenous miR-223 sponge to sequester and inhibit miR-223 activity, which resulted in the increase of ARC expression. Heart-related circRNA directly bound to miR-223 in cytoplasm and enforced expression of HRCR in cardiomyocytes and in mice both exhibited attenuated hypertrophic responses. These findings disclose a novel regulatory pathway that is composed of HRCR, miR-223, and ARC. Modulation of their levels provides an attractive therapeutic target for the treatment of cardiac hypertrophy and heart failure.
引用
收藏
页码:2602 / U24
页数:11
相关论文
共 47 条
[1]   The impact of microRNAs on protein output [J].
Baek, Daehyun ;
Villen, Judit ;
Shin, Chanseok ;
Camargo, Fernando D. ;
Gygi, Steven P. ;
Bartel, David P. .
NATURE, 2008, 455 (7209) :64-U38
[2]   CIRCULAR TRANSCRIPTS OF THE TESTIS-DETERMINING GENE SRY IN ADULT-MOUSE TESTIS [J].
CAPEL, B ;
SWAIN, A ;
NICOLIS, S ;
HACKER, A ;
WALTER, M ;
KOOPMAN, P ;
GOODFELLOW, P ;
LOVELLBADGE, R .
CELL, 1993, 73 (05) :1019-1030
[3]   MicroRNA-133 controls cardiac hypertrophy [J].
Care, Alessandra ;
Catalucci, Daniele ;
Felicetti, Federica ;
Bonci, Desiree ;
Addario, Antonio ;
Gallo, Paolo ;
Bang, Marie-Louise ;
Segnalini, Patrizia ;
Gu, Yusu ;
Dalton, Nancy D. ;
Elia, Leonardo ;
Latronico, Michael V. G. ;
Hoydal, Morten ;
Autore, Camillo ;
Russo, Matteo A. ;
Dorn, Gerald W., II ;
Ellingsen, Oyvind ;
Ruiz-Lozano, Pilar ;
Peterson, Kirk L. ;
Croce, Carlo M. ;
Peschle, Cesare ;
Condorelli, Gianluigi .
NATURE MEDICINE, 2007, 13 (05) :613-618
[4]   The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation [J].
Chen, JF ;
Mandel, EM ;
Thomson, JM ;
Wu, QL ;
Callis, TE ;
Hammond, SM ;
Conlon, FL ;
Wang, DZ .
NATURE GENETICS, 2006, 38 (02) :228-233
[5]   Target protectors reveal dampening and balancing of nodal agonist and antagonist by miR-430 [J].
Choi, Wen-Yee ;
Giraldez, Antonio J. ;
Schier, Alexander F. .
SCIENCE, 2007, 318 (5848) :271-274
[6]   MISSPLICING YIELDS CIRCULAR RNA MOLECULES [J].
COCQUERELLE, C ;
MASCREZ, B ;
HETUIN, D ;
BAILLEUL, B .
FASEB JOURNAL, 1993, 7 (01) :155-160
[7]   Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress [J].
Donath, S ;
Li, PF ;
Willenbockel, C ;
Al-Saadi, N ;
Gross, V ;
Willnow, T ;
Bader, M ;
Martin, U ;
Bauersachs, J ;
Wollert, KC ;
Dietz, R ;
von Harsdorf, R .
CIRCULATION, 2006, 113 (09) :1203-1212
[8]   ANGIOTENSIN RECEPTOR REGULATES CARDIAC-HYPERTROPHY AND TRANSFORMING GROWTH FACTOR-BETA(1) EXPRESSION [J].
EVERETT, AD ;
TUFROMCREDDIE, A ;
FISHER, A ;
GOMEZ, RA .
HYPERTENSION, 1994, 23 (05) :587-592
[9]   microRNA-22 Promotes Heart Failure through Coordinate Suppression of PPAR/ERR-Nuclear Hormone Receptor Transcription [J].
Gurha, Priyatansh ;
Wang, Tiannan ;
Larimore, Ashley H. ;
Sassi, Yassine ;
Abreu-Goodger, Cei ;
Ramirez, Maricela O. ;
Reddy, Anilkumar K. ;
Engelhardt, Stefan ;
Taffet, George E. ;
Wehrens, Xander H. T. ;
Entman, Mark L. ;
Rodriguez, Antony .
PLOS ONE, 2013, 8 (09)
[10]   Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells [J].
Hahn, Nynke E. ;
Musters, Rene J. P. ;
Fritz, Jan M. ;
Pagano, Patrick J. ;
Vonk, Alexander B. A. ;
Paulus, Walter J. ;
van Rossum, Albert C. ;
Meischl, Christof ;
Niessen, Hans W. M. ;
Krijnen, Paul A. J. .
CELLULAR SIGNALLING, 2014, 26 (09) :1818-1824